In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia ; day:7 ; month:4 ; year:2023 ; pages:1-9
Indian journal of hematology and blood transfusion ; (7.4.2023), 1-9
- Creator
-
Hanafy, Rana M.
Demian, Soheir R.
Abou-Shamaa, Lobna A.
Ghallab, O.
Osman, Eman M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12288-023-01649-y
- URN
-
urn:nbn:de:101:1-2023082021065575747446
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hanafy, Rana M.
- Demian, Soheir R.
- Abou-Shamaa, Lobna A.
- Ghallab, O.
- Osman, Eman M.
- SpringerLink (Online service)
Other Objects (12)
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model
TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model
TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model